An Overview on the Toxic Morphological Changes in the Retinal Pigment Epithelium after Systemic Compound Administration

Abstract

Many medications that are administered systemically for nonocular conditions may evoke ocular toxicological complications. Therefore, the eye is routinely investigated histopathologically in preclinical in vivo toxicity studies. The retinal pigment epithelium is a likely target for systemically administered compounds, since the underlying choroid is highly vascularized. The specialized pigment epithelium has numerous functions that all maintain the integrity and function of photoreceptors. Consequently, toxic effects on the pigment epithelium will eventually affect the neural retina. The potential of pigment epithelial cells to respond to toxic injury is limited, but a standardized terminology to describe its morphological changes does not exist in the scientific literature. Detailed morphologic analysis, however, might allow early detection of retinotoxicity and may provide evidence on the underlying pathomechanism. We here review toxic effects on the pigment epithelium focusing in particular on the morphology of toxic cell injury. Morphological changes comprise hypertrophy, intracytoplasmic accumulation of cellular components, loss of cell polarity, degeneration, metaplasia, and formation of subretinal membranes. Some of these changes are reversible whereas others are permanent, leading to impaired function of the pigment epithelium and eventually to photoreceptor loss and retinal atrophy.

A novel automated segmentation method for retinal layers in OCT images proves retinal degeneration after optic neuritis

“…The RPE layer mainly serves as a barrier between the retina and the circulatory system 25. An increase in the thickness of this layer is well documented in age-related retinal degeneration studies, in which retinal pathology is a result of chronic inflammatory damage 26 27.…”

TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90α and β, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models

“…The observed symptoms include night blindness, photopsia, blurred vision, and visual impairment, which are likely associated with retinal dysfunction (20,21). Two independent reports of rodent models suggest that HSP90 plays a critical role in retinal function and that sustained HSP90 inhibition might adversely affect visual function (34,49). Therefore, ocular effects may be minimized by reducing retinal exposure.…”

Ultrastructural Changes in the Retina during the Process of Paclitaxel-Induced Retinotoxicity Correction using Antioxidant Drug

“…Водно-час спостерігаються побічні реакції на паклітаксел, у тому числі, й порушення зору [9,15,5]. На думку дослідників, у патогенезі порушень зору відіграють роль кілька факторів, серед яких структурні зміни пігментного епітелію, що призводить до порушень його взаємодії з фоторецепторним шаром сітківки, загибеллю паличок і колбочок шляхом апоптозу й некрозу [10,4]. Ці процеси відбуваються на тлі оки-слювальних ушкоджень, тісно пов'язаних із мітохо-ндріальною дисфункцією клітин [14,7,12,6].…”